Hypertension Patients on Drug Medication Adherence and Rational Medication Use

The Effect of Education and Telephone Counseling Given to Hypertension Patients on Drug Medıcation Adherence and Rational Medication Use: Single-Blind Randomized Controlled Trial

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Study Overview

• Status: Completed
• Conditions: Hypertension Patients
• Intervention / Treatment: Other: Education and Telephone Counceling

Detailed Description

This research will be conducted to determine the effects of education and telephone counseling given to hypertension patients on drug treatment compliance and rational drug use.

Research Hypotheses H0: Education and telephone counseling given to hypertension patients do not affect drug treatment compliance.

H1: Education and telephone counseling given to hypertension patients increase drug treatment compliance.

H0: Education and telephone counseling given to hypertension patients do not affect rational drug use.

H1: Education and telephone counseling given to hypertension patients increase rational drug use.

This study was planned as a single-blind randomized controlled experimental study.

• Study Type: Interventional
• Enrollment (Actual): 84
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Turkey
  • Cumhuriyet Campus Cumhuriyet District
    • Ordu, Cumhuriyet Campus Cumhuriyet District, Turkey, 52200
      • Hacer GÖK UĞUR

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• - Diagnosed with hypertension,
• Hypertension disease duration of at least 6 months,
• Using at least one drug due to hypertension,
• 18 years old and over
• Literate,
• Living in the town centre,
• Owns a phone
• Open to communication and cooperation,
• Patients willing to participate in the study will be included in the study.

Exclusion Criteria:

• Having a psychiatric illness
• Hearing loss,
• Can't understand or speak Turkish and
• Patients who do not wish to continue the study will be excluded from the study.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: SUPPORTIVE_CARE
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: DOUBLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: EDUTC; Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.	Other: Education and Telephone Counceling; Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.
ACTIVE_COMPARATOR: Control Group; Routine hospital care.	Other: Education and Telephone Counceling; Drug use and rational drug use training will be given to hypertension patients in the experimental group. The patients in the experimental group twice in the 1st month (2nd and 4th weeks), once in the 2nd month (8th week) and once in the 3rd month (12th week) phone call counseling will be providedved an average of 10-15 minutes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Adherence to Medication Self-Efficacy Scale	The scale consists of 13 items and determines the self-efficacy/confidence level of adherence to drug treatments of individuals with hypertension. The scale is evaluated by scoring from 1 to 4 in each question. The minimum score that can be obtained from the scale is 13, and the maximum score is 52. The increase in the scale score indicates that the compliance of individuals to antihypertensive drug treatment increases positively.	12 weeks
Rational Drug Use Scale	The scale has 36 items and is a triple Likert type. Behavioral beliefs (items 1-9), Control beliefs (items 10-16), Attitude (items 17-21), Subjective norm (items 22-23), Intention (items 24-28), and Knowledge It has 6 sub-dimensions (items between 29 and 36). Scoring of scale items was never (0), sometimes (1), and always (2) for positive items; negative items (items 13, 14, 17, 18, 19, 20, 21, and 24) are calculated as never (2), sometimes (1), and always (0). The scores that can be obtained from the scale range from 0 to 72. As the score obtained from the scale increases, the level of rational drug use increases.	12 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Diastolic/Systolic blood pressure	Systolic and Diastolic blood pressure will be measured.	12 weeks

Collaborators and Investigators

• Sponsor: T.C. ORDU ÜNİVERSİTESİ
• Investigators: Principal Investigator: Hacer GÖK UĞUR, Assoc., Ordu Univercity

Study record dates

Study Major Dates

• Study Start (ACTUAL): October 1, 2021
• Primary Completion (ACTUAL): May 1, 2022
• Study Completion (ACTUAL): June 1, 2022

Study Registration Dates

• First Submitted: September 18, 2021
• First Submitted That Met QC Criteria: September 18, 2021
• First Posted (ACTUAL): September 29, 2021

Study Record Updates

• Last Update Posted (ACTUAL): October 18, 2022
• Last Update Submitted That Met QC Criteria: October 14, 2022
• Last Verified: October 1, 2022

More Information

Terms related to this study

• Keywords: Hypertension; Nursing; Education; Tele nursing; Rational medication use; Drug medication adherence
• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Hypertension
• Other Study ID Numbers: ayyuzlum3207

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No